167 related articles for article (PubMed ID: 22335239)
1. Human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSC) inhibit the proliferation of K562 (human erythromyeloblastoid leukaemic cell line).
Fonseka M; Ramasamy R; Tan BC; Seow HF
Cell Biol Int; 2012 Sep; 36(9):793-801. PubMed ID: 22335239
[TBL] [Abstract][Full Text] [Related]
2. Human umbilical cord blood-derived mesenchymal stem cells prevent diabetic renal injury through paracrine action.
Park JH; Hwang I; Hwang SH; Han H; Ha H
Diabetes Res Clin Pract; 2012 Dec; 98(3):465-73. PubMed ID: 23026513
[TBL] [Abstract][Full Text] [Related]
3. Rapid exit from G0/G1 phases of cell cycle in response to stem cell factor confers on umbilical cord blood CD34+ cells an enhanced ex vivo expansion potential.
Traycoff CM; Abboud MR; Laver J; Clapp DW; Srour EF
Exp Hematol; 1994 Dec; 22(13):1264-72. PubMed ID: 7525328
[TBL] [Abstract][Full Text] [Related]
4. Shockwave stimulates oxygen radical-mediated osteogenesis of the mesenchymal cells from human umbilical cord blood.
Wang FS; Yang KD; Wang CJ; Huang HC; Chio CC; Hsu TY; Ou CY
J Bone Miner Res; 2004 Jun; 19(6):973-82. PubMed ID: 15125794
[TBL] [Abstract][Full Text] [Related]
5. Human umbilical cord blood mesenchymal stem cell-derived PGE2 and TGF-β1 alleviate atopic dermatitis by reducing mast cell degranulation.
Kim HS; Yun JW; Shin TH; Lee SH; Lee BC; Yu KR; Seo Y; Lee S; Kang TW; Choi SW; Seo KW; Kang KS
Stem Cells; 2015 Apr; 33(4):1254-66. PubMed ID: 25522163
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of Melanoma Cell Adhesion Molecule (MCAM/CD146) Accelerates Cellular Senescence in Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells.
Jin HJ; Kwon JH; Kim M; Bae YK; Choi SJ; Oh W; Yang YS; Jeon HB
Stem Cells Transl Med; 2016 Apr; 5(4):427-39. PubMed ID: 26941359
[TBL] [Abstract][Full Text] [Related]
7. Migration of human umbilical cord blood mesenchymal stem cells mediated by stromal cell-derived factor-1/CXCR4 axis via Akt, ERK, and p38 signal transduction pathways.
Ryu CH; Park SA; Kim SM; Lim JY; Jeong CH; Jun JA; Oh JH; Park SH; Oh WI; Jeun SS
Biochem Biophys Res Commun; 2010 Jul; 398(1):105-10. PubMed ID: 20558135
[TBL] [Abstract][Full Text] [Related]
8. Equine mesenchymal stem cells inhibit T cell proliferation through different mechanisms depending on tissue source.
Carrade Holt DD; Wood JA; Granick JL; Walker NJ; Clark KC; Borjesson DL
Stem Cells Dev; 2014 Jun; 23(11):1258-65. PubMed ID: 24438346
[TBL] [Abstract][Full Text] [Related]
9. A study on mutual interaction between cytokine induced killer cells and umbilical cord-derived mesenchymal cells: Implication for their in-vivo use.
Chieregato K; Albiero E; Castegnaro S; Bernardi M; d'Amore ES; Zanon C; Madeo D; Rodeghiero F; Astori G
Blood Cells Mol Dis; 2012 Oct 15-Dec 15; 49(3-4):159-65. PubMed ID: 22818859
[TBL] [Abstract][Full Text] [Related]
10. Conditioned Media from Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Inhibits Melanogenesis by Promoting Proteasomal Degradation of MITF.
Kim ES; Jeon HB; Lim H; Shin JH; Park SJ; Jo YK; Oh W; Yang YS; Cho DH; Kim JY
PLoS One; 2015; 10(5):e0128078. PubMed ID: 26024475
[TBL] [Abstract][Full Text] [Related]
11. Analysis of oxygen-dependent cytokine expression in human mesenchymal stem cells derived from umbilical cord.
Lönne M; Lavrentieva A; Walter JG; Kasper C
Cell Tissue Res; 2013 Jul; 353(1):117-22. PubMed ID: 23579552
[TBL] [Abstract][Full Text] [Related]
12. Human umbilical cord blood-derived stromal cell, a new resource of feeder layer to expand human umbilical cord blood CD34+ cells in vitro.
Gao L; Chen X; Zhang X; Liu Y; Kong P; Peng X; Liu L; Liu H; Zeng D
Blood Cells Mol Dis; 2006; 36(2):322-8. PubMed ID: 16500123
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem cells of human placenta and umbilical cord suppress T-cell proliferation at G0 phase of cell cycle.
Vellasamy S; Sandrasaigaran P; Vidyadaran S; Abdullah M; George E; Ramasamy R
Cell Biol Int; 2013 Mar; 37(3):250-6. PubMed ID: 23364902
[TBL] [Abstract][Full Text] [Related]
14. The lack of NK cytotoxicity associated with fresh HUCB may be due to the presence of soluble HLA in the serum.
Webb BJ; Bochan MR; Montel A; Padilla LM; Brahmi Z
Cell Immunol; 1994 Dec; 159(2):246-61. PubMed ID: 7994757
[TBL] [Abstract][Full Text] [Related]
15. Fetal BM-derived mesenchymal stem cells promote the expansion of human Th17 cells, but inhibit the production of Th1 cells.
Guo Z; Zheng C; Chen Z; Gu D; Du W; Ge J; Han Z; Yang R
Eur J Immunol; 2009 Oct; 39(10):2840-9. PubMed ID: 19637224
[TBL] [Abstract][Full Text] [Related]
16. Mitigating effects of hUCB-MSCs on the hematopoietic syndrome resulting from total body irradiation.
Shim S; Lee SB; Lee JG; Jang WS; Lee SJ; Park S; Lee SS
Exp Hematol; 2013 Apr; 41(4):346-53.e2. PubMed ID: 23333483
[TBL] [Abstract][Full Text] [Related]
17. Effect of interleukin-12 on antitumor activity of human umbilical cord blood and bone marrow cytotoxic cells.
Condiotti R; Nagler A
Exp Hematol; 1998 Jul; 26(7):571-9. PubMed ID: 9657131
[TBL] [Abstract][Full Text] [Related]
18. Low immunogenicity of allogeneic human umbilical cord blood-derived mesenchymal stem cells in vitro and in vivo.
Lee M; Jeong SY; Ha J; Kim M; Jin HJ; Kwon SJ; Chang JW; Choi SJ; Oh W; Yang YS; Kim JS; Jeon HB
Biochem Biophys Res Commun; 2014 Apr; 446(4):983-9. PubMed ID: 24657442
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow mesenchymal stem cells suppressing activation of allogeneic cytokine-induced killer/natural killer cells either by direct or indirect interaction.
Li Y; Qu YH; Wu YF; Liu L; Lin XH; Huang K; Wei J
Cell Biol Int; 2015 Apr; 39(4):435-45. PubMed ID: 25492047
[TBL] [Abstract][Full Text] [Related]
20. Human umbilical cord mesenchymal stem cells as vehicles of CD20-specific TRAIL fusion protein delivery: a double-target therapy against non-Hodgkin's lymphoma.
Yan C; Li S; Li Z; Peng H; Yuan X; Jiang L; Zhang Y; Fan D; Hu X; Yang M; Xiong D
Mol Pharm; 2013 Jan; 10(1):142-51. PubMed ID: 23121392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
